Barclays
May 15, 2026
Americas Small Cap Research Summary
Market ReportEquitiesHealth CareConsumer Discretionary
This Barclays Equity Research report provides a summary of rating and estimate changes for several Americas small-cap companies across healthcare, retail, financials, and technology sectors as of May 15, 2026.
Key Takeaways
- 1.Addus Homecare (ADUS) faces significant operational headwinds due to a CMS Medicare home health and hospice moratorium, halting incremental supply and near-term M&A.
- 2.Canada Goose (GOOS) reported strong sales growth (+18%) but carries risks to its FY27 guidance due to mix shifts impacting gross margins and broader macro challenges.
- 3.Anteris Technologies (AVR) remains on track for its PARADIGM pivotal trial enrollment by 1Q27, with management amping up focus on clinical execution.
Table of Contents
- Summary of Changes
- Publications Summary
- Financial Services
- Healthcare
- Industrials
- Retail
- Technology
- Analyst(s) Certification(s)
- Important Disclosures
- Availability of Disclosures
- Risk Disclosure(s)
- Guide to the Barclays Fundamental Equity Research Rating System
- Guide to the Barclays Research Price Target
- Disclaimer
Document Preview
Access the Full Report
Get unlimited access to institutional research reports with a 14-day free trial.
Authors
Alex Scott, CFAAndrew Mok, CFAAdrienne Yih
Securities
ADUSGOOSAVR
Themes
Small-Cap VolatilityRegulatory HeadwindsClinical Trial Execution
Regions
North AmericaUnited StatesCanada
